Top 10 Articles on GenomeWeb in 2022: Illumina, Invitae, 10x Genomics, Natera, Element, Ultima, More
Over the past year, GenomeWeb readers were most interested in layoffs at genomics companies, Illumina's business, and new sequencing technology firms.
IDbyDNA Nabs Additional Funding for Gene Editing Dx, Biosurveillance Tech
In collaboration with other firms, IDbyDNA is using precision metagenomics to develop a next-generation device for diagnostic testing of emerging infectious diseases.
The company's DETECTR disease detection platform will be used to help develop the technology and optimize the CRISPR enzymes used in the point-of-care device.
DARPA Awards $36.7M to Six Organizations for Gene Editing-Based Dx, Biosurveillance Tech
The contract was awarded under DARPA's Detect It with Gene Editing Technologies program, which aims to create a device to detect at least 10 pathogens.